Friday 26th June 2020
|
|||
| 3.45 | WELCOME Àngel Font, Corporate Director of Scientific Research, “la Caixa” Foundation, Barcelona, Spain. Bonaventura Clotet, Director of the IrsiCaixa AIDS Research Institute, Barcelona, Spain. |
||
| 4 to 5:30 pm – Immunomodulation
(Chairs: Daria Hazuda, Merck, West Point, NY, USA and Roger Paredes, IrsiCaixa AIDS Research Institute. Hospital Germans Trias i Pujol, Barcelona, Spain). |
|||
| 4.00-4.30 | Linking the Microbiome with Immunity
Roger Paredes, IrsiCaixa AIDS Research Institute. Hospital Germans Trias i Pujol, Barcelona, Spain. |
||
| 4.30-5.00 | Diet, microbiome and inflammaging
Paul O’Toole, University College Cork, Ireland. |
||
| 5.00-5.30 | Questions and Answers | ||
| 6 to 7:30 pm – Microbiome and Non-Communicable Disease
(Chairs: Xavier Aldeguer, Hospital Doctor Josep Trueta, Girona, Spain and Chaysavanh Manichanh, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain). |
|||
| 6.00-6.30 | Dysbiosis in Mental Disorders
Premysl Bercik, McMaster University, Hamilton, Canada. |
||
| 6.30-7.00 | Microbiome and Tolerance to Gluten
Elena Verdu, McMaster University, Hamilton, Canada. |
||
| 7.00-7.30 | Questions and Answers | ||
Saturday 27th June 2020
|
| 4 to 5:30 pm– Microbiome-wide Association Studies
(Chairs: Maria del Carmen Collado, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Valencia, Spain and Marc Noguera, IrsiCaixa AIDS Research Institute. Hospital Germans Trias i Pujol, Barcelona, Spain). |
|||
| 4.00-4.30 | The American Gut project
Rob Knight, University of California San Diego, USA. |
||
| 4.30-5.00 | The “Twins UK” Cohort
Tim Spector, King’s College London, UK. |
||
| 5.00-5.30 | Questions and Answers | ||
| 6 to 7:30 pm – The Missing Microbes
(Chairs: Francisco Guarner, Vall d’Hebron Research Institute, Barcelona, Spain). |
|||
| 6.00-6.30 | Microbiome and Virome of Non-Westernised Communities
Gloria Dominguez Bello, Rutgers University, New Brunswick, USA. |
||
| 6.30-7.00 | Paradoxical effects of antibiotics on infectious and inflammatory diseases
Martin Blaser, Center for Advanced Biotechnology and Medicine, USA. |
||
| 7.00-7.30 | Questions and Answers | ||
| 7.30 | CLOSING Francisco Guarner, Senior Investigator at Vall d’Hebron Research Institute, Barcelona, Spain. |
||